|
|
Article: Research and Markets: Evaluate the Key Markets of Medicare Part D and Discover the Market Impact, Key Therapeutic Areas and Future Outlook of the Programme.
- Article from:
- Business Wire
- Article date:
- September 22, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/be227e/key_markets_in_med) has announced the addition of Decision Resources, Inc.'s new report "Key Markets in Medicare Part D" to their offering.
Medicare Part D, the outpatient prescription drug benefit introduced in January 2006, had an immediate impact on the U.S. pharmaceutical market and now accounts for almost one-fifth of prescription drug sales.
Cardiovascular diseases, metabolic disorders, infectious diseases, immune/inflammatory disorders, and several other key conditions account for a substantial share of Medicare Part D prescribing. This report, featuring 36 ...